Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[S,S]-Reboxetine in Postherpetic Neuralgia
NCT00288652Phase 2Completed
- Sponsor
- Pfizer
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of reboxetine in postherpetic neuralgia (PHN), sponsored by Pfizer. Started Mar 2006; status: completed.
02
Drugs
reboxetine
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT00288652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00288652.